DJIA 17,640.52 -32.08 -0.18%
NASDAQ 4,762.11 4.23 0.09%
S&P 500 2,051.86 0.04 0.00%
market minute promo

Merck & Co., Inc. (NYSE: MRK)



company name or ticker
Company Photos
(Click to zoom)

A New Price Estimate Now That Afrezza Is Launching

This Popular Beverage Could Be Responsible For a 20% Reduction in Melanoma Risk

The good news: this beverage reduced the risk of an aggressive form of skin cancer by 20% in a very large study. The better news: 83% of you are already consuming this beverage on a daily basis!

Pharmaceuticals Sector To See High Voltage Action in 2015

Bristol-Myers Squibb Earnings Preview: Increasing Sales From New Drugs May Ease The Pressure Off Rev

Bristol-Myers Squibb Earnings Preview: Increasing Sales From New Drugs May Ease The Pressure Off Revenue Growth

XLV, JNJ, PFE, MRK: Large Outflows Detected at ETF

Celgene to Use Zymeworks' Azymetric Platform for New Drugs - Analyst Blog

How you can cash in on the dollar’s coming decline

Young Investors Are Buying the Wrong Stocks

Despite what you may think, investing in young and exciting companies isn't the best way to build wealth over the long run.

ARIAD Pharmaceuticals: Is The Ship Turning Around?

50% Upside For Gilead In 2015

See More Articles...